<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=271082&amp;fmt=gif">

Janssen Sciences, the Wasdell Group & Brexit

17 May | By Smart MBS

Why The Pharma Industry Chooses Ireland-1

At the turn of the twentieth century, the unincorporated town of Las Vegas had a population of just twenty-two people. Fast forward to 2016 and the city now has a population of just under 700,000, while almost 43 million tourists passed through the city in same year.

The growth in population and tourism is even more impressive when you consider the Las Vegas valley is a parched, arid landscape where only the hardiest animals and plants survive.

The growth in the Irish Pharmaceutical industry is a similar story; an unlikely location yet the settlers have prospered achieving incredible growth.

Ireland can now boast some impressive statistics when it comes to the Pharma industry

  • 75 global pharmaceutical companies operate in Ireland including all 10 of the world's top 10 pharmaceutical companies including Pfizer, Merck and Johnson & Johnson
  • Ireland was the 7th largest exporter of medicinal and pharmaceutical products in the world in 2015 with €54bn in annual exports of pharma, bio and chemistry produce
  • There are 90 pharma and biopharma plants based in Ireland, 40 are FDA approved

Ireland offers a young, highly skilled workforce

Ireland has an abundance of human capital with the youngest and fastest growing labour force in Europe.

Over 27% of undergrad enrolments were in the areas of Natural Sciences, ICT or Engineering in 2015/2016 academic year.

Ireland has a significant track record in clinical and academic research too. The National Institute for Bioprocess Research and Training (NIBRT), created from a €60million investment by the IDA, gave practical training to 2,000 people in 2013.

Based on the above, overseas companies can choose Ireland with confidence knowing their will have ample qualified candidates to hire.

Janssen Sciences In Ireland

  • Company – Janssen Sciences
  • Location – Cork
  • Announcement – “650 jobs for Cork as pharma player Janssen reveals expansion”

Janssen Sciences Ireland is part of the Johnson & Johnson family of companies, the largest pharmaceutical company in the world by revenue. It has had a presence in Ireland since 1981, with 3,700 people employed at eleven sites.

Janssen Pharmaceuticals Sciences UC has since opened in Cork. This plant based in Little Island is responsible for manufacturing bulk active pharmaceutical ingredients. These ingredients are then exported throughout the world to other Janssen and third-party companies to be processed into various forms of medicines.

Janssen Sciences Ireland UC opened in Ringaskiddy, also in Cork, in 2005. The 100-acre site was built with an investment of €400 million.

This latest expansion is quite significant and will cost €300 million. It includes the construction of a new manufacturing facility and the upgrade of existing warehouses, labs and offices as well as improvements to the campus infrastructure.

The entire project is expected to take approximately two years and will require up to 450 people during the construction period.

Once construction is complete a further 200 people will be employed permanently by Janssen at the facility.

“This expansion project is a significant vote of confidence in our team and one which will increase our manufacturing footprint very significantly, allowing us to continue to meet critical patient needs in the areas of multiple myeloma, rheumatoid arthritis and Crohn’s disease.” - Kyran Johnson, general manager of Janssen Supply Chain Ireland.

Wasdell Group In Ireland

  • Company – Wasdell Group
  • Location – Louth
  • Announcement – “Wasdell Group to establish Pharmaceutical Packaging & Distribution Facility in Dundalk, Co Louth creating 300 jobs over five years”

The Wasdell Group was established in 1971 and employs over 500 people at multiple sites across the UK. It provides the pharmaceutical and nutraceutical industries with a variety of outsourcing solutions such as technical, manufacturing, packaging and storage/distribution services.

The 70,000 sq. ft. greenfield facility will be built in Mullagharlin, just outside Dundalk in County Louth. It’s expected the investment will cost €30 million and will become the company's EU hub post Brexit.

This is the Wasdell Group’s first foray into Ireland. Speaking about the announcement Martin Tedham, Wasdell Group MD acknowledged the move had a lot to do with the significant size of the Irish Pharmaceutical sector and the implications Brexit would have on his business.

“We have always had a strong customer base in Ireland and we are certain that this trend will continue with the impending Brexit situation as companies typically from the UK and USA look to secure a base to service their European markets”.

Smart MBS is here to help

In the global economy, expanding your business can be a huge challenge. In addition to the normal rules and regulations associated with a cross border move, new variables, like Brexit, can add another layer of complexity to the issue.

Smart MBS have extensive experience dealing with International companies expanding into Ireland. If expansion is one of your goals for 2018 and beyond contact us today to find out more about how we can make it happen for your company.

Topics: Expanding Overseas, Ireland, Brexit, Global Business Expansion



View our Privacy Policy

Most Popular Posts

Recent Posts